Coloplast A/S (LON:0QBO)

Market Cap	15.81B
Revenue (ttm)	3.12B
Net Income (ttm)	509.58M
Shares Out	n/a
EPS (ttm)	2.26
PE Ratio	31.02
Forward PE	25.61
Dividend	2.46 (0.40%)
Ex-Dividend Date	May 8, 2025

Volume	25,059
Average Volume	54,469
Open	615.10
Previous Close	612.72
Day's Range	600.20 - 615.20
52-Week Range	583.20 - 959.00
Beta	0.55
RSI	36.42
Earnings Date	Aug 19, 2025

About Coloplast

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the B...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1954
• Employees: 16,639
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QBO

Financial Performance

In 2024, Coloplast's revenue was 27.03 billion, an increase of 10.33% compared to the previous year's 24.50 billion. Earnings were 5.05 billion, an increase of 5.62%.

Financial numbers in DKK